Congress 2025 - Friday

Wondering what Human Factors are and how we apply them to improve patient safety in practice?

In this interactive, workshop we will demystify the discipline of Human Factors. Examining several patient safety scenarios through a Human Factors lens and considering how we can make those scenarios safer for both the patient and the team. Participants will be encouraged to share their thoughts and ideas, leaving with a practical toolbox which will they can take back to practice.

This session is vital for anyone involved in small animal clinical practice. Canine atopic dermatitis is a common skin condition that requires life-long therapy. Following a diagnosis of atopic dermatitis, dogs require careful and regular monitoring. We will discuss how to identify and manage flare factors, what therapy can be used to help prevent flares in a proactive manner. The proactive approach to canine atopic dermatitis will be discussed to include therapy (systemic and topical), owner education and how the RVN can also play a vital role in these cases.

Abstract unavailable.

• Insights into the work of Government including - animal & public health and, government guidance.
• Insights from the author of the BSAVA Scientific Information Document (SID).
• How Government & BSAVA collaborate to address concerns of practice staff and pet owners.

All material produced by civil servants, ministers, and government departments and agencies belong to the Crown and is Crown copyright.

How to be Salmonella Savvy

• The occurrence of salmonella and its relevance to small animal vets in practice, pet owners and pets.
• The legislation relating to salmonella and companion animals and, the obligations of vets in practice.
• The zoonotic potential of salmonella for vets and owners.

Parasiticides & the Environment

We all have cases of otitis externa every day in the clinic that can quickly establish as a chronic and frustrating problem for the patient, owner and vet. By using the PSPP system to help us understand the driving forces behind the OE, we can help prevent the establishment of chronic OE. There are many treatment options for OE which can be oberwhealming, but through providing you with the fundamental basis for selecting a product, this selection process can be made easier. We will discuss what topical products to use and how to select the optimal treatment plan. For cases of Pseudomonas, some additional investigation and potentially therapy needs to be considered, this will be highlighted to help you select the best plan or your next Pseudomonas case.

This session discusses the following:

• Do pain scores work (in all species) - Pain scores are increasingly popular and being used for more and more species, but how should be use the opinion they give us to drive optimal clinical standards and welfare.
• Do we give too many opioids - Opioids are the most potent analgesic drugs we have available to us, but do we overuse them, and do we always factor in the side effects these drugs come with and how they alter the presentation of patient, painful or dysphoric?
• Why are we not as good at chronic pain as we are at acute pain - We normalise chronic pain, its often accepted as being a normal part of aging, and therefore less important to manage then acute pain, how do we improve this issue and therefore animal welfare.

Abstract unavailable.

Abstract unavailable.